James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 1,040 shares at $49.26 ($51K) on 2026-10-14, disclosed to the SEC on 2026-10-15.
Open-market sale of $51k CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2026-03-24 | $149K | — | Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |